G1 Therapeutics (GTHX) stock forecast for 2022. Forecast tables and graphs.

G1 Therapeutics (GTHX) stock forecast for 2022

The forecast has been updated: June 13, 2021 12:23


G1 Therapeutics stock price online today

Analyst Target Price

59

Dividend Date

-

Ex Dividend Date

-

Last Split Factor

None

Last Split Date

-

Should you buy or sell G1 Therapeutics stock stock today? What is the projected target price level for 2022? How much will it cost in 2022? G1 Therapeutics stock Stock Monthly Prediction for January, February, March, April, May, July, July, August, September, October, November and December 2022.

We predict the dynamics of the stock market value using resonant artificial intelligence systems.

Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.

Forecasts are adjusted once a day taking into account the price change of the previous day.

To date, analysts have a $59 target price for G1 Therapeutics stock stock.

Today 200 Day Moving Average is the resistance level (21.9868 $).

50 Day Moving Average is the resistance level (21.3409 $).




GTHX Forecast for 2022

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 24.83 21.81 28.25 22.78 %
Feb 25.30 21.34 27.01 20.99 %
Mar 23.18 19.11 25.31 24.48 %
Apr 22.05 18.66 24.44 23.64 %
May 19.61 16.06 21.15 24.04 %
Jun 21.78 17.96 24.08 25.40 %
Jul 20.37 19.05 22.30 14.55 %
Aug 25.87 22.24 31.46 29.31 %
Sep 30.97 24.28 34.90 30.43 %
Oct 36.99 34.20 39.89 14.27 %
Nov 46.98 39.50 50.41 21.64 %
Dec 41.78 39.41 44.60 11.63 %

The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility of G1 Therapeutics stock.


G1 Therapeutics overview

G1 Therapeutics Address

700 Park Offices Drive, Research Triangle Park, NC, United States, 27709

Market Capitalization

909 646 400 $

EBITDA

-105 136 000

PE Ratio

None

PEG Ratio

0

Dividend Per Share

None

Dividend Yield

0

EPS

-2.703

Quarterly Earnings Growth YOY

0

Quarterly Revenue Growth YOY

0

Trailing PE

0

Forward PE

0

EV To Revenue

11.4417

EV To EBITDA

0

52 Week High

37.069

52 Week Low

10.81

50 Day Moving Average

21.3409

200 Day Moving Average

21.9868

Shares Outstanding

42074300

Shares Float

35122395

Shares Short Prior Month

6428798

Short Ratio

6.68

Percent Insiders

8.957

Percent Institutions

72.525

G1 Therapeutics stock forecast for this year


G1 Therapeutics stock forecast for Jan 2022.
Estimated Average Forecasted G1 Therapeutics Price: 24.83. Negative monthly dynamics of the instrument is expected with 22.783% volatility is expected.

Pessimistic forecast: 21.81

Optimistic: 28.25


G1 Therapeutics stock forecast for Feb 2022.
Estimated Average Forecasted G1 Therapeutics Price: 25.30. Positive monthly dynamics of the instrument is expected with 20.993% volatility is expected.

Pessimistic forecast: 21.34

Optimistic: 27.01


G1 Therapeutics stock forecast for Mar 2022.
Estimated Average Forecasted G1 Therapeutics Price: 23.18. Negative monthly dynamics of the instrument is expected with 24.482% volatility is expected.

Pessimistic forecast: 19.11

Optimistic: 25.31


G1 Therapeutics stock forecast for Apr 2022.
Estimated Average Forecasted G1 Therapeutics Price: 22.05. Negative monthly dynamics of the instrument is expected with 23.637% volatility is expected.

Pessimistic forecast: 18.66

Optimistic: 24.44


G1 Therapeutics stock forecast for May 2022.
Estimated Average Forecasted G1 Therapeutics Price: 19.61. Negative monthly dynamics of the instrument is expected with 24.038% volatility is expected.

Pessimistic forecast: 16.06

Optimistic: 21.15


G1 Therapeutics stock forecast for Jun 2022.
Estimated Average Forecasted G1 Therapeutics Price: 21.78. Positive monthly dynamics of the instrument is expected with 25.405% volatility is expected.

Pessimistic forecast: 17.96

Optimistic: 24.08


G1 Therapeutics stock forecast for Jul 2022.
Estimated Average Forecasted G1 Therapeutics Price: 20.37. Negative monthly dynamics of the instrument is expected with 14.555% volatility is expected.

Pessimistic forecast: 19.05

Optimistic: 22.30


G1 Therapeutics stock forecast for Aug 2022.
Estimated Average Forecasted G1 Therapeutics Price: 25.87. Positive monthly dynamics of the instrument is expected with 29.309% volatility is expected.

Pessimistic forecast: 22.24

Optimistic: 31.46


G1 Therapeutics stock forecast for Sep 2022.
Estimated Average Forecasted G1 Therapeutics Price: 30.97. Positive monthly dynamics of the instrument is expected with 30.428% volatility is expected.

Pessimistic forecast: 24.28

Optimistic: 34.90


G1 Therapeutics stock forecast for Oct 2022.
Estimated Average Forecasted G1 Therapeutics Price: 36.99. Positive monthly dynamics of the instrument is expected with 14.272% volatility is expected.

Pessimistic forecast: 34.20

Optimistic: 39.89


G1 Therapeutics stock forecast for Nov 2022.
Estimated Average Forecasted G1 Therapeutics Price: 46.98. Positive monthly dynamics of the instrument is expected with 21.642% volatility is expected.

Pessimistic forecast: 39.50

Optimistic: 50.41


G1 Therapeutics stock forecast for Dec 2022.
Estimated Average Forecasted G1 Therapeutics Price: 41.78. Negative monthly dynamics of the instrument is expected with 11.635% volatility is expected.

Pessimistic forecast: 39.41

Optimistic: 44.60



Other Healthcare sector assets

Name Symbol Last Close Price Change
Abbott Laboratories
ABT 110.48 (14.06.2021) 0.52 %
AbbVie Inc.
ABBV 115.4 (14.06.2021) -0.02 %
Aeterna Zentaris Inc.
AEZS 1.02 (14.06.2021) -2.86 %
Allakos Inc.
ALLK 90.87 (14.06.2021) -3.24 %
Allogene Therapeutics, Inc.
ALLO 25.37 (14.06.2021) -2.80 %
Amgen Inc.
AMGN 241.19 (14.06.2021) -0.65 %
Aphria Inc.
APHA 15.38 (07.05.2021) 0.00 %
Atara Biotherapeutics, Inc.
ATRA 14.66 (14.06.2021) 1.81 %
Aurora Cannabis Inc.
ACB 9.67 (14.06.2021) -1.53 %
Becton Dickinson and Company
BDX 242.72 (14.06.2021) 0.03 %
Biogen Inc.
BIIB 406.14 (14.06.2021) 2.40 %
Biohaven Pharmaceutical Holding Company Ltd.
BHVN 100.4 (14.06.2021) -4.40 %
BioNTech SE
BNTX 220.58 (14.06.2021) -7.53 %
bluebird bio, Inc.
BLUE 33.53 (14.06.2021) -1.67 %
Boston Scientific Corp.
BSX 42.54 (14.06.2021) -0.86 %
Bristol-Myers Squibb Company
BMY 67.29 (14.06.2021) -0.07 %
Canopy Growth Corp.
CGC 25.14 (14.06.2021) -2.82 %
Castle Biosciences, Inc.
CSTL 71.86 (14.06.2021) -0.04 %
Eli Lilly and Company
LLY 226.1 (14.06.2021) 0.90 %
Emergent BioSolutions Inc.
EBS 61.79 (14.06.2021) -2.71 %
Exelixis, Inc.
EXEL 22.76 (14.06.2021) -0.96 %
G1 Therapeutics, Inc.
GTHX 22.75 (14.06.2021) 5.23 %
Gilead Sciences, Inc.
GILD 68.15 (14.06.2021) -0.90 %
GlaxoSmithKline plc
GSK 40.49 (14.06.2021) 0.85 %
GoodRx Holdings, Inc.
GDRX 38.33 (14.06.2021) 4.21 %
GW Pharmaceuticals plc.
GWPH 218.96 (05.05.2021) 0.00 %
Incyte Corp.
INCY 82.64 (14.06.2021) 0.07 %
Inovio Pharmaceuticals, Inc.
INO 8.63 (15.06.2021) -3.14 %
Johnson & Johnson
JNJ 165.37 (14.06.2021) 0.25 %
Medtronic plc.
MDT 124.15 (14.06.2021) 0.30 %
Merck & Co., Inc.
MRK 75.45 (14.06.2021) -1.08 %
Moderna, Inc.
MRNA 207.41 (14.06.2021) -5.23 %
Novartis AG
NVS 93.59 (14.06.2021) 0.97 %
Novavax, Inc.
NVAX 207.71 (14.06.2021) -0.94 %
ObsEva SA
OBSV 3.17 (14.06.2021) -0.63 %
OrganiGram Holdings Inc.
OGI 3.08 (15.06.2021) -1.91 %
Pfizer Inc.
PFE 39.63 (14.06.2021) -1.30 %
Regeneron Pharmaceuticals, Inc.
REGN 528.75 (14.06.2021) 0.61 %
Sanofi
SNY 54.25 (14.06.2021) 0.84 %
Schrodinger, Inc.
SDGR 76.34 (14.06.2021) -1.51 %
Senseonics Holdings, Inc.
SENS 3.96 (14.06.2021) -1.25 %
Sorrento Therapeutics, Inc.
SRNE 9.46 (14.06.2021) 6.65 %
Stryker Corp.
SYK 255.69 (14.06.2021) -0.04 %
Sundial Growers Inc.
SNDL 1.06 (14.06.2021) 0.95 %
Teva Pharmaceutical Industries Lim. (TEVA)
TEVA 11.05 (14.06.2021) -0.54 %
Thermo Fisher Scientific Inc.
TMO 470.07 (14.06.2021) 1.06 %
Tilray, Inc.
TLRY 19.16 (14.06.2021) -3.67 %
UnitedHealth Group, Inc.
UNH 399.16 (14.06.2021) 0.32 %
Veeva Systems Inc.
VEEV 303.9 (14.06.2021) 1.57 %
Zomedica Corp.
ZOM 0.9458 (14.06.2021) -0.08 %
Zynerba Pharmaceuticals, Inc.
ZYNE 5.66 (14.06.2021) 0.35 %


Denial of responsibility:

The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.